© 2016 Macmillan Publishers Limited. Promoters are DNA sequences that have an essential role in controlling gene expression. While recent whole cancer genome analyses have identified numerous hotspots of somatic point mutations within promoters, many have not yet been shown to perturb gene expression or drive cancer development. As such, positive selection alone may not adequately explain the frequency of promoter point mutations in cancer genomes. Here we show that increased mutation density at gene promoters can be linked to promoter activity and differential nucleotide excision repair (NER). By analysing 1,161 human cancer genomes across 14 cancer types, we find evidence for increased local density of somatic point mutations within the ...
Cancer is a disease that is strongly related to evolution, as mutations that confer a benefit to ind...
Most cancer DNA sequencing studies have prioritized recurrent non-synonymous coding mutations in ord...
Whole genomes are being sequenced at an accelerated pace but research into cancer causing mutations ...
© 2016 Macmillan Publishers Limited. Promoters are DNA sequences that have an essential role in cont...
Sequencing of whole cancer genomes has revealed an abundance of recurrent mutations in gene-regulato...
Sequencing of whole cancer genomes has revealed an abundance of recurrent mutations in gene-regulato...
Carcinogenesis and neoplastic progression are mediated by the accumulation of somatic mutations. Her...
Somatic mutations are the driving force of cancer genome evolution. The rate of somatic mutations ap...
© 2015 American Association for Cancer Research. With the recent discovery of recurrent mutations i...
Background: The identification of mutations that play a causal role in tumour development, so called...
Aberrant regulation of gene expression in cancer can promote survival and proliferation of cancer ce...
SummarySomatic mutations in cancer are more frequent in heterochromatic and late-replicating regions...
Somatic mutations in cancer are more frequent in heterochromatic and late-replicating regions of the...
Bidirectional gene promoters affect the transcription of two genes, leading to the hypothesis that t...
Many processes can cause the same nucleotide change in a genome, making the identification of the m...
Cancer is a disease that is strongly related to evolution, as mutations that confer a benefit to ind...
Most cancer DNA sequencing studies have prioritized recurrent non-synonymous coding mutations in ord...
Whole genomes are being sequenced at an accelerated pace but research into cancer causing mutations ...
© 2016 Macmillan Publishers Limited. Promoters are DNA sequences that have an essential role in cont...
Sequencing of whole cancer genomes has revealed an abundance of recurrent mutations in gene-regulato...
Sequencing of whole cancer genomes has revealed an abundance of recurrent mutations in gene-regulato...
Carcinogenesis and neoplastic progression are mediated by the accumulation of somatic mutations. Her...
Somatic mutations are the driving force of cancer genome evolution. The rate of somatic mutations ap...
© 2015 American Association for Cancer Research. With the recent discovery of recurrent mutations i...
Background: The identification of mutations that play a causal role in tumour development, so called...
Aberrant regulation of gene expression in cancer can promote survival and proliferation of cancer ce...
SummarySomatic mutations in cancer are more frequent in heterochromatic and late-replicating regions...
Somatic mutations in cancer are more frequent in heterochromatic and late-replicating regions of the...
Bidirectional gene promoters affect the transcription of two genes, leading to the hypothesis that t...
Many processes can cause the same nucleotide change in a genome, making the identification of the m...
Cancer is a disease that is strongly related to evolution, as mutations that confer a benefit to ind...
Most cancer DNA sequencing studies have prioritized recurrent non-synonymous coding mutations in ord...
Whole genomes are being sequenced at an accelerated pace but research into cancer causing mutations ...